§ Comparison
MOTS-c vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
MOTS-c
22
vendors tracked
from $2.48/mg
Tirzepatide
10
vendors tracked
from $2.08/mg
◎ Cheapest $/mg:Tirzepatide at $2.08/mg
MOTS-c
Mitochondrial exerkine
No current listings at 5mg.
Tirzepatide
Dual GLP-1/GIP agonist
B-
Operational$24.00
$2.40/mg
In stock◎ Best $/mg
Operational
$89.99
$9.00/mg
In stock▲ 275.0% vs best
B-
Operational$99.00
$9.90/mg
In stock▲ 312.5% vs best
Watch
$99.99
$10.00/mg
In stock▲ 316.6% vs best
Operational
$286.20
$28.62/mg
In stockOn sale▲ 1092.5% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| RetaOneLabs US | B- | Operational | $24.00 ◎ Best $/mg | $2.40 | In stock | Buy with code → | |
| One Day Compounds US | B- | Operational | $89.99 ▲ 275.0% | $9.00 | In stock | Visit → | |
| Atomik Labz US | B- | Operational | $99.00 ▲ 312.5% | $9.90 | In stock | Visit → | |
| Felix Chemical Supply US | B- | Watch | $99.99 ▲ 316.6% | $10.00 | In stock | Visit → | |
| Research Peptides Europe EU | A | Operational | $286.20 On sale ▲ 1092.5% | $28.62 | In stock | Visit → |
Sort:
Last crawl 2026-05-04Sort:
2026-05-04About MOTS-c
A 16-residue peptide encoded within the mitochondrial 12S rRNA. Studied as an exercise-mimetic exerkine for metabolic health and longevity.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.